EMEA-002827-PIP01-20
Key facts
Active substance |
Linear single strand of deoxyribonucleic acid (encoding human retinitis pigmentosa GTPase regulator [RPGR]) packaged in a recombinant adeno-associated virus protein capsid of serotype 5 (AAV5-hRKp.RPGR)
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/0125/2021
|
PIP number |
EMEA-002827-PIP01-20
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of Retinitis Pigmentosa
|
Route(s) of administration |
Ophthalmic use
|
Contact for public enquiries |
Janssen-Cilag International NV
E-mail: contact@janssen-emea.com |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|